0000903423-16-001363.txt : 20161114 0000903423-16-001363.hdr.sgml : 20161111 20161114164642 ACCESSION NUMBER: 0000903423-16-001363 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20161103 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Preston Heather CENTRAL INDEX KEY: 0001606826 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 161995601 MAIL ADDRESS: STREET 1: C/O TPG GLOBAL, LLC STREET 2: 301 COMMERCE STREET CITY: FORT WORTH STATE: TX ZIP: 76102 3 1 preston.xml OWNERSHIP DOCUMENT X0206 3 2016-11-03 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001606826 Preston Heather C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 1 0 0 0 No securities beneficially owned 0 D Dr. Heather Preston is a TPG Partner. TPG is affiliated with TPG Biotechnology Partners II, L.P. ("TPG Biotech II"), which holds 568,638 shares of the Common Stock of Albireo Pharma, Inc. (the "Issuer"), and TPG Biotech II Reinvest AIV L.P. ("TPG Biotech II Reinvest"), which holds 208,458 shares of the Common Stock of the Issuer. Dr. Preston disclaims beneficial ownership of all of the securities that are or may be beneficially owned by TPG Biotech II or TPG Biotech II Reinvest or any of their affiliates. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that Dr. Preston is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities of the Issuer for purposes of Section 16 of the Exchange Act or otherwise. (3) Michael LaGatta is signing on behalf of Dr. Preston pursuant to the authorization and designation letter dated October 6, 2016, which is filed as an exhibit to this Form 3. /s/ Michael LaGatta on behalf of Dr. Heather Preston (3) 2016-11-14 EX-24 2 prestonpoa.htm

October 6, 2016

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

This letter confirms that Michael LaGatta, Ken Murphy and Joann Harris are authorized and designated to sign all securities related filings under Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, with the Securities and Exchange Commission, including Form ID Acknowledgements, on my behalf. This authorization and designation shall be valid until December 31, 2019.

Very truly yours,

/s/ Heather Preston
Heather Preston

GRAPHIC 3 image_010.jpg GRAPHIC begin 644 image_010.jpg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end